Predicting Response to Rifaximin in Irritable Bowel Syndrome with Diarrhea: Is the Answer Blowing in the Wind?

Gastroenterology. 2020 Apr;158(5):1508-1510. doi: 10.1053/j.gastro.2020.02.018. Epub 2020 Feb 15.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breath Tests
  • Diarrhea
  • Humans
  • Irritable Bowel Syndrome*
  • Lactulose
  • Rifamycins*
  • Rifaximin

Substances

  • Rifamycins
  • Lactulose
  • Rifaximin